BioSpace News Archive

C Spire is teaming up with the Delta Regional Medical Center to debut a remote patient monitoring program in Mississippi for a broad array of chronic medical conditions that will help manage health care costs for hospitals in rural areas and improve the quality of life for patients.

Usona Institute has published a breakthrough technique in kilogram-scale synthesis of pharmaceutical grade psilocybin in the open-access journal ACS Omega.

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2020 second quarter on Thursday, August 6, 2020, after market close.

Calmare Therapeutics Incorporated announced that the independent medical review organization, in a rereview case filed with the California Department of Insurance, recommended overturning an insurance treatment coverage denial by the UnitedHealthcare Insurance Company for Calmare Pain Mitigation Therapy™ in the treatment of Complex Regional Pain Syndrome.

ArisGlobal, the leading provider of life sciences software that automates drug development functions for over 300 life sciences companies, today announced that a large, top five global biopharmaceutical company has selected its LifeSphere MultiVigilance safety system as the foundation of its next-generation pharmacovigilance technology environment. I

To make it easier for members to fill and manage multiple prescriptions, Horizon Healthcare Services, Inc. (Horizon), New Jersey’s oldest and largest health insurer, and its pharmacy benefit manager Prime Therapeutics LLC, now offer its members an integrated pharmacy experience with PillPack by Amazon Pharmacy.

Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, is very pleased that the Sean M Healey & AMG Center for ALS at Mass General announced the first patients have been enrolled into the HEALEY ALS Platform Trial being conducted at sites of the Northeast ALS (NEALS) consortium.

Ocean Bio-Chem, Inc. announced that its subsidiary, Kinpak Inc., has commissioned a third production line for the manufacturing of its disinfectant/sanitizer product group Performacide®.

Study will allow The Lundquist Institute to determine the multi-generational risks of developing asthma from vaping while pregnant

Rx-360, an international pharmaceutical consortium dedicated to supply chain integrity and patient safety is very excited to announce the expansion of its Audit Program